Beyond Air (XAIR) Return on Invested Capital (2017)

Beyond Air's (XAIR) quarterly Return on Invested Capital came in at 0.01% in Q3 2017, up 177.17% quarter-over-quarter from 0.01% in Q2 2017.

Beyond Air (XAIR) Return on Invested Capital (2017) Analysis & Trends

Beyond Air has disclosed Return on Invested Capital across 1 years of filings, most recently posting 0.01% for Q3 2017.

Return on Invested Capital for Q3 2017 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2017 was 0.01% (changed N/A YoY), and the FY2022 annual result was 0.07%, down 5.0% from the prior year.
Return on Invested Capital came in at 0.01% for Q3 2017 at Beyond Air, up from 0.01% in the prior quarter.
In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2017 to a low of 0.01% in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.00%
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.00%
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.00%
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.00%
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.00%
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	0.00%
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.00%
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.00%
10	Beyond Air	2.53 Mn	-7.33 Mn	300,000.00	-

Download Data